Cara Therapeutics SG&A Expense (Quarterly) Insights

Cara Therapeutics Inc (CARA)

0.7782 +0.01 (+0.78%) USD | NASDAQ | May 03, 16:00

0.7787 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2012. Upgrade now.

Date	Value
December 31, 2023	6.549M
September 30, 2023	6.724M
June 30, 2023	7.514M
March 31, 2023	6.862M
December 31, 2022	6.396M
September 30, 2022	6.88M
June 30, 2022	7.538M
March 31, 2022	9.315M
December 31, 2021	11.48M
September 30, 2021	5.851M
June 30, 2021	5.62M
March 31, 2021	6.334M
December 31, 2020	6.628M
September 30, 2020	5.195M
June 30, 2020	5.389M
March 31, 2020	4.537M
December 31, 2019	4.596M
September 30, 2019	4.204M
June 30, 2019	4.972M
March 31, 2019	3.886M
December 31, 2018	4.689M
September 30, 2018	3.206M
June 30, 2018	3.665M

Date	Value
March 31, 2018	3.677M
December 31, 2017	2.976M
September 30, 2017	3.785M
June 30, 2017	2.653M
March 31, 2017	2.381M
December 31, 2016	2.019M
September 30, 2016	2.081M
June 30, 2016	2.405M
March 31, 2016	2.10M
December 31, 2015	2.037M
September 30, 2015	1.776M
June 30, 2015	1.833M
March 31, 2015	1.733M
December 31, 2014	1.702M
September 30, 2014	1.429M
June 30, 2014	1.382M
March 31, 2014	1.307M
December 31, 2013	0.737M
September 30, 2013	0.795M
June 30, 2013	1.033M
March 31, 2013	0.588M
December 31, 2012	0.379M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

4.204M

Minimum

Sep 2019

11.48M

Maximum

Dec 2021

6.452M

Average

6.396M

Median

Dec 2022

SG&A Expense (Quarterly) Benchmarks